ID
42072
Beschreibung
Study ID: 110921 Clinical Study ID: 110921 Study Title: A Phase II Trial of Ofatumumab in Subjects with Waldenstrom's Macroglobulinemia Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00811733 Clinicaltrials.gov Link: https://clinicaltrials.gov/ct2/show/NCT00811733 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Ofatumumab Trade Name: N/A Study Indication: Waldenstrom Macroglobulinaemia The primary objective of this open-label, multi-center, Phase II study was to evaluate the safety and efficacy of Ofatumumab in subjects diagnosed with Waldenstrom Macroglobulinaemia. For the study, eligible subjects were enrolled to receive up to 3 cycles of treatment with Ofatumumab. The first cycle consisted of a single dose of 300 mg followed by 3 weekly doses of 1000 mg (Treatment Group A) or 4 weekly doses of 2000 mg (Treatment Group B) of Ofatumumab, with response assessment beginning at Week 12. Based on the Week 12-16 response, eligible subjects could receive up to 2 additional cycles of treatment. This form has to be filled out at the screening visit, the first and last weekly visits during treatment cycles (week 1 and week 4), cycle observation visits, possible unscheduled and withdrawal visits.
Link
https://clinicaltrials.gov/ct2/show/NCT00811733
Stichworte
Versionen (1)
- 16.03.21 16.03.21 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
16. März 2021
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
GSK Ofatumumab in Waldenstrom Macroglobulinaemia, NCT00811733
Local Lab Assessments
- StudyEvent: ODM
Beschreibung
Laboratory Information
Alias
- UMLS CUI-1
- C0022877
- UMLS CUI-2
- C1533716
Beschreibung
[hidden]
Datentyp
text
Alias
- UMLS CUI [1]
- C2986056
Beschreibung
[read only]
Datentyp
text
Alias
- UMLS CUI [1]
- C0022877
Beschreibung
Select the correct laboratory number, based on the laboratories entered in the LABS form.
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C1524063
- UMLS CUI [1,2]
- C0022877
Beschreibung
Local Lab Assessments
Alias
- UMLS CUI-1
- C0022877
- UMLS CUI-2
- C0205276
- UMLS CUI-3
- C0431080
Beschreibung
Cryoglobulin
Datentyp
text
Alias
- UMLS CUI [1]
- C0202093
Beschreibung
Cryoglobulin measurement, positive
Datentyp
integer
Maßeinheiten
- %
Alias
- UMLS CUI [1,1]
- C0202093
- UMLS CUI [1,2]
- C1446409
Beschreibung
Cold agglutinin measurement, Titer, numerator
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0201281
- UMLS CUI [1,2]
- C0475208
- UMLS CUI [1,3]
- C2825219
Beschreibung
Cold agglutinin measurement, Titer, denominator
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0201281
- UMLS CUI [1,2]
- C0475208
- UMLS CUI [1,3]
- C2825218
Beschreibung
Serum viscosity
Datentyp
float
Alias
- UMLS CUI [1,1]
- C0229671
- UMLS CUI [1,2]
- C0042784
Beschreibung
Rheumatoid factor measurement, Titer, numerator
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0201660
- UMLS CUI [1,2]
- C0475208
- UMLS CUI [1,3]
- C2825219
Beschreibung
Rheumatoid factor measurement, Titer, denominator
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0201660
- UMLS CUI [1,2]
- C0475208
- UMLS CUI [1,3]
- C2825218
Ähnliche Modelle
Local Lab Assessments
- StudyEvent: ODM
C2985720 (UMLS CUI [2])
C1533716 (UMLS CUI-2)
C0022877 (UMLS CUI [1,2])
C0205276 (UMLS CUI-2)
C0431080 (UMLS CUI-3)
C1446409 (UMLS CUI [1,2])
C0475208 (UMLS CUI [1,2])
C2825219 (UMLS CUI [1,3])
C0475208 (UMLS CUI [1,2])
C2825218 (UMLS CUI [1,3])
C0042784 (UMLS CUI [1,2])
C0475208 (UMLS CUI [1,2])
C2825219 (UMLS CUI [1,3])
C0475208 (UMLS CUI [1,2])
C2825218 (UMLS CUI [1,3])